Clinical features of elderly-onset Adult-onset Still’s disease

References

• Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M. Adult Still’s disease: review of 228 cases from the literature. J Rheumatol 1987;14:1139–46.
   PubMed Web of Science ®Google Scholar
• Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H, et al. Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol 1990;17:1058–63.
   PubMed Web of Science ®Google Scholar
• Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Sève P. Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart. Immunol Res. 2015;61(1-2):53–62.
   PubMed Web of Science ®Google Scholar
• Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M. The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 2011;41:279–85.
   PubMed Web of Science ®Google Scholar
• Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P. Adult-onset Still’s disease. Autoimmun Rev.2014;13(7):708–22.
   PubMed Web of Science ®Google Scholar
• Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still's disease. J Autoimmun. 2018;93:24–36.
   PubMed Web of Science ®Google Scholar
• Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, Sumida T. Nationwide epidemiological survey of 169 patients with adult Still’s disease in Japan. Mod Rheumatol.2015;25(3):393–400.
   PubMed Web of Science ®Google Scholar
• Sakata N, Shimizu S, Hirano F, Fushimi K. Epidemiological study of adult-onset Still's disease using a Japanese administrative database. Rheumatol Int. 2016;36(10):1399–405.
   PubMed Web of Science ®Google Scholar
• Stoica GS, Cohen RI. Rossoff Adult Still’s disease and respiratory failure in a 74 year old woman. Postgrad Med J. 2002;78(916):97–8.
   PubMed Web of Science ®Google Scholar
• Rubenstein EJ, Arkfeld DG. Adult Still's disease in a 75-year-old patient. J Am Geriatr Soc. 2004;52(12):2144–5.
   PubMed Web of Science ®Google Scholar
• Vila LM, Molina MJ. Chronic anemia and thrombocytosis as the initial presentation of Still’s disease in an elderly patient. Gerontology. 2007;53:289–92.
   PubMed Web of Science ®Google Scholar
• Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T. Adult-onset Still's disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy. Age Ageing. 2007;36(1):104–6.
   PubMed Web of Science ®Google Scholar
• Rech J, Ronneberger M, Englbrecht M, Finzel S, Katzenbeisser J, Manger K, et al. Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Ann Rheum Dis. 2011;70(2):390–2.
   PubMed Web of Science ®Google Scholar
• Ertugrul BM, Gencer P, Ozturk B, Saylak Ersoy OM, Sakarya S. Adult-onset Still's disease in an 83-year-old. J Am Geriatr Soc. 2012;60(1):162–4.
   PubMed Web of Science ®Google Scholar
• Suda T, Zoshima T, Takeji A, Suzuki Y, Mizushima I, Yamada K, et al. Elderly-onset Still's disease complicated by macrophage activation syndrome: a case report and review of the literature. Intern Med. 2020;59(5):721–8.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kshiwagi H, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol 1992;19:424–30.
   PubMed Web of Science ®Google Scholar
• Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol. 2004;14(3):205–15.
   PubMedGoogle Scholar
• Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.
   PubMed Web of Science ®Google Scholar
• Tada Y, Inokuchi S, Maruyama A, Suematsu R, Sakai M, Sadanaga Y, et al. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease? Rheumatol Int. 2019;39(1):97–104.
   PubMed Web of Science ®Google Scholar
• Asakura H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, et al. DIC subcommittee of the Japanese Society on Thrombosis and Hemostasis: proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016;14:42.
   PubMedGoogle Scholar
• Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M, et al. Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991;70(2):118–36.
   PubMed Web of Science ®Google Scholar
• Narváez Garcia FJ, Pascual M, López de Recalde M, Juarez P, Morales-Ivorra I, Notario J, et al. Adult-onset Still’s disease with atypical cutaneous manifestations. Medicine (Baltimore). 2017; 96:e6318.
   PubMed Web of Science ®Google Scholar
• Boddaert J, Huong DLT, Amoura Z, Wechsler B, Godeau P, Piette J-C. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83(6):348–59.
   PubMed Web of Science ®Google Scholar
• Ichida H, Kawaguchi Y, Sugiura T, Takagi K, Katsumata Y, Gono T, et al. Clinical manifestations of adult-onset Still’s disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18. Arthritis Care Res. 2014;66(4):642–6.
   PubMed Web of Science ®Google Scholar
• Schulert GS, Grom AA. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol. 2014;28(2):277–92.
   PubMed Web of Science ®Google Scholar
• Lenert A, Yao Q. Macrophage activation syndrome complicating adult onset Still’s disease: a single center case series and comparison with literature. Semin Arthritis Rheum. 2016;45(6):711–6.
   PubMed Web of Science ®Google Scholar
• Suematsu R, Ohta A, Matsuura E, Takahashi H, Fujii T, Horiuchi T, et al. Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan. Mod Rheumatol 2012;22(5):712–9.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Kameda H, Ikeda K, Ishii T, Murakami K, Takamatsu H, et al. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Ann Rheum Dis. 2018;77(12):1720–9.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Cipriani P, Masedu F, Iacono D, Ciccia F, Liakouli V, et al. Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMC Med 2016;14(1):194.
   PubMed Web of Science ®Google Scholar
• Yang XP, Wang M, Li TF, Li W, Zhang L, Liu SY. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still’s disease. Clin Exp Rheumatol. 2019; 37 (Suppl 121):83–8.
   PubMedGoogle Scholar
• Kim Y, Koo B, Kim Y, Lee C, Yoo B. Clinical features and prognosis in 82 patients with adult-onset Still’s disease. Clin Exp Rheumatol. 2014;32:28–33.
   PubMed Web of Science ®Google Scholar